WHO backs wider use of weight
For people with obesity , these medicines can lead to significant weight loss and health improvements. WHO added them to its Essential Medicines List in 2025 for managing type 2 diabetes in high-risk groups, and its new guidelines now recommend their long-term use for adults living with obesity , except during pregnancy.
In December 2025 , WHO published the guideline on the use of glucagon-like peptide-1 (GLP-1) therapies for the treatment of obesity in adults. This guideline aims to support the safe, equitable and appropriate inclusion of pharmacological therapy for adults as part of comprehensive obesity chronic care programmes.
American Association of Clinical Endocrinology Consensus Statement ...
This 2025 algorithm for the medical care of adults with obesity underscores that ABCD is a complex, chronic disease that necessitates long-term treatment and care. Emphasis is placed on optimizing health rather than just weight reduction and achieving clinical goals other than a singular focus on body mass index (ie, complication ...
On present trends, the world will not meet the World Health Assembly's 2025 targets for the prevention and control of non-communicable diseases (NCDs) which include a 'halt in the rise in diabetes and obesity' and a '25% relative reduction in overall premature mortality from cardiovascular diseases, cancer, diabetes or chronic ...
Obesity as a Chronic Disease
As we can see from the illustration, 2025 Obesity Is A Chronic has many fascinating aspects to explore.
Obesity is a chronic disease of dysfunctional adipose tissue that is driven by the dysregulation of energy homeostasis and chronic low-grade inflammation. Body mass index, while commonly used, provides a limited evaluation of obesity and there is an ongoing push to use anthropometric measurements like waist circumference that can more specifically identify excess adiposity. Weight-inclusive ...
Obesity is a chronic , biologically driven, and progressive disease. It contributes to more than 200 health conditions, including diabetes, cardiovascular disease, and multiple cancers.1 Yet in global policy, it remains largely invisible.
Obesity is a chronic disease of dysfunctional adipose tissue and chronic low-grade inflammation that is driven by genetic, biologi-cal, environmental, and behavioral factors.
Overweight and obesity
Overweight or obesity is the second leading risk factor (after tobacco use) for many preventable chronic conditions, such as heart disease, some cancers and type@2 diabetes. More Australians in...
Obesity has emerged as one of the most pressing global public health challenges of the 21st century. In 2022, more than 1 billion people worldwide were living with obesity (body mass index ≥30) - roughly one in eight adults - and about 43 % of adults were classified as overweight or obese [1]. The prevalence of adult obesity has more than doubled since 1990, and childhood obesity rates ...
